MicroRNA Expression in Human Blood Serum and Vitreous Body

March 31, 2015 updated by: Kazunari Hirota, Kyorin University
MicroRNAs are important regulators of many cellular functions but their expression profile in human vitreous is still unclear. Aim of this study is to investigate microRNA expression profile by PCR in human vitreous of macula hole patients which is suggested to be similar to that of healthy patients.

Study Overview

Study Type

Observational

Enrollment (Actual)

8

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mitakasi Sinkawa6-20-2
      • Tokyo, Mitakasi Sinkawa6-20-2, Japan, 181-8611
        • Kyorin University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Female pateints undergoing vitrectomy for macula hole without previous ocular or systemic disease

Description

Inclusion Criteria:

  • Female macula hole patients without previous ocular or systemic disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
human vitreous, human blood serum, PCR
Vitreous and bloodserum samples from macula hole patients without previous ocular or systemic disease
1ml of human vitreous and 3ml of human blood serum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
MicroRNA expression profile in human vitreous investigated by PCR
Time Frame: 1month
1month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

October 26, 2011

First Submitted That Met QC Criteria

October 27, 2011

First Posted (Estimate)

October 31, 2011

Study Record Updates

Last Update Posted (Estimate)

April 1, 2015

Last Update Submitted That Met QC Criteria

March 31, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • No. 461

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on MicroRNA Expression Profile in Human Vitreous

Clinical Trials on human vitreous and blood serum sampling, PCR

3
Subscribe